We are live on ! Find out more
OPTN

OptiNose
OPTN

Delisted

OPTN was delisted on the 20th of May, 2025.

Back to rankings

53 hedge funds and large institutions have $207M invested in OptiNose in 2017 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.97% more ownership

Funds ownership: 0% → 1.97% (+2%)

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$106M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$11M
3
CWAM
Columbia Wanger Asset Management
Illinois
+$8M
4
PCM
Peregrine Capital Management
Minnesota
+$6.27M
5
PHS
PFM Health Sciences
California
+$6.06M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$103M +$106M +378,150 New
Massachusetts Financial Services
2
Massachusetts Financial Services
Massachusetts
$11.1M +$11M +39,049 New
FCMI
3
Foresite Capital Management IV
California
$8.51M +$8.44M +30,000 New
CWAM
4
Columbia Wanger Asset Management
Illinois
$8.06M +$8M +28,432 New
PCM
5
Peregrine Capital Management
Minnesota
$6.31M +$6.27M +22,271 New
PHS
6
PFM Health Sciences
California
$6.1M +$6.06M +21,528 New
KCM
7
Kornitzer Capital Management
Kansas
$6.04M +$5.99M +21,304 New
ACM
8
Asymmetry Capital Management
California
$5.68M +$5.64M +20,041 New
WRF
9
Waddell & Reed Financial
Kansas
$5.6M +$5.56M +19,761 New
DCM
10
Driehaus Capital Management
Illinois
$5.52M +$5.48M +19,473 New
Wells Fargo
11
Wells Fargo
California
$5.39M +$5.35M +19,020 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$4.94M +$4.9M +17,416 New
BlackRock
13
BlackRock
New York
$4.35M +$4.32M +15,351 New
PCM
14
Prelude Capital Management
New York
$2.98M +$2.95M +10,492 New
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$2.83M +$2.81M +10,000 New
Neuberger Berman Group
16
Neuberger Berman Group
New York
$2.52M +$2.51M +8,906 New
OAM
17
Oxford Asset Management
United Kingdom
$2.3M +$2.26M +8,020 New
Ameriprise
18
Ameriprise
Minnesota
$2.29M +$2.28M +8,091 New
NCGI
19
Next Century Growth Investors
Minnesota
$2.01M +$2M +7,103 New
American Century Companies
20
American Century Companies
Missouri
$1.75M +$1.73M +6,154 New
Northern Trust
21
Northern Trust
Illinois
$1.41M +$1.4M +4,988 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$1.36M +$1.35M +4,786 New
IBT
23
International Biotechnology Trust
United Kingdom
$1.23M +$1.22M +4,333 New
MWNA
24
Marshall Wace North America
New York
$844K +$837K +2,976 New
Macquarie Group
25
Macquarie Group
Australia
$512K +$508K +1,806 New
1
2 3

OPTN Hedge Fund Activity: Q4 2017 in Review

53 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2017, worth a combined $207M.

Buyers outnumbered sellers: 53 funds opened new OPTN positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $106M.

  • 53 institutional investors held OptiNose (OPTN) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $207M of OptiNose stock for Q4 2017.
  • 53 funds opened new OptiNose positions in Q4 2017 and 0 closed out, a net change of +53 holders.
  • The largest OptiNose buyer in Q4 2017 was Fidelity Investments, an estimated $106M added.

Based on aggregated 13F filings for Q4 2017.